Generalized least squares for assessing trends in cumulative meta-analysis with applications in genetic epidemiology

Journal of Clinical Epidemiology

Volumn 62, Issue 10, 2009, Pages 1037-1044

  Bagos, Pantelis G ^a   Nikolopoulos, Georgios K ^b  

^a UNIVERSITY OF CENTRAL GREECE   (Greece)

^b Hellenic Centre for Disease Control and Prevention   (Greece)

Author keywords

Autocorrelation; Cumulative meta analysis; Generalized least squares; Genetic association studies; Genetic epidemiology; Meta analysis

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CORRELATION ANALYSIS; EFFECT SIZE; GENETIC EPIDEMIOLOGY; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL ANALYSIS;

COMPUTATIONAL BIOLOGY; EVIDENCE-BASED MEDICINE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEAST-SQUARES ANALYSIS; META-ANALYSIS AS TOPIC; MODELS, STATISTICAL; MOLECULAR EPIDEMIOLOGY;

EID: 69949095752     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2008.12.008     Document Type: Article

References (37)

1. Trikalinos T.A., Salanti G., Zintzaras E., and Ioannidis J.P. Meta-analysis methods. Adv Genet 60 (2008) 311-334
2. Normand S.L. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 18 (1999) 321-359
3. Beecher H.K. The powerful placebo. JAMA 159 (1955) 1602-1606
4. Glass G. Primary, secondary and meta-analysis of research. Educ Res 5 (1976) 3-8
5. Feinstein A.R. Meta-analysis: statistical alchemy for the 21st century. J Clin Epidemiol 48 (1995) 71-79
6. Egger M., and Smith G.D. Meta-analysis. potentials and Promise. BMJ 315 (1997) 1371-1374
7. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. JAMA 283 (2000) 2008-2012
8. Burton P.R., Tobin M.D., and Hopper J.L. Key concepts in genetic epidemiology. Lancet 366 (2005) 941-951
9. Little J., Bradley L., Bray M.S., Clyne M., Dorman J., Ellsworth D.L., et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 156 (2002) 300-310
10. Lau J., Schmid C.H., and Chalmers T.C. Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol 48 (1995) 45-57 discussion 59-60
11. Lau J., Antman E.M., Jimenez-Silva J., Kupelnick B., Mosteller F., and Chalmers T.C. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327 (1992) 248-254
12. Patsopoulos N.A., Analatos A.A., and Ioannidis J.P. Relative citation impact of various study designs in the health sciences. JAMA 293 (2005) 2362-2366
13. Ioannidis J.P. Contradicted and initially stronger effects in highly cited clinical research. JAMA 294 (2005) 218-228
14. LeLorier J., Gregoire G., Benhaddad A., Lapierre J., and Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 337 (1997) 536-542
15. Ioannidis J., and Lau J. Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses. Proc Natl Acad Sci U S A 98 (2001) 831-836
16. Trikalinos T.A., Churchill R., Ferri M., Leucht S., Tuunainen A., Wahlbeck K., et al. Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time. J Clin Epidemiol 57 (2004) 1124-1130
17. Ioannidis J.P. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA 279 (1998) 281-286
18. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 29 (2001) 306-309
19. Trikalinos T.A., Ntzani E.E., Contopoulos-Ioannidis D.G., and Ioannidis J.P. Establishment of genetic associations for complex diseases is independent of early study findings. Eur J Hum Genet 12 (2004) 762-769
20. Ioannidis J.P., and Trikalinos T.A. Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials. J Clin Epidemiol 58 (2005) 543-549
21. Ioannidis J.P. Molecular bias. Eur J Epidemiol 20 (2005) 739-745
22. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 7 (1986) 177-188
23. Thompson S.G., and Sharp S.J. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 18 (1999) 2693-2708
24. Petiti D.B. Meta-analysis Decision Analysis and Cost-Effectiveness Analysis (1994), Oxford University Press, New York
25. Ioannidis J.P., Trikalinos T.A., Ntzani E.E., and Contopoulos-Ioannidis D.G. Genetic associations in large versus small studies: an empirical assessment. Lancet 361 (2003) 567-571
26. Bagos P.G., Elefsinioti A.L., Nikolopoulos G.K., and Hamodrakas S.J. The GNB3 C825T polymorphism and essential hypertension: a meta-analysis of 34 studies including 14,094 cases and 17,760 controls. J Hypertens 25 (2007) 487-500
27. Egger M., Smith D.G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
28. Berrington A., and Cox D.R. Generalized least squares for the synthesis of correlated information. Biostatistics 4 (2003) 423-431
29. Greenland S., and Longnecker M.P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135 (1992) 1301-1309
30. Berlin J.A., Longnecker M.P., and Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology 4 (1993) 218-228
31. Shi J.Q., and Copas J.B. Meta-analysis for trend estimation. Stat Med 23 (2004) 3-19 discussion 159-162
32. Bagos P.G., Karnaouri A.C., Nikolopoulos G.K., and Hamodrakas S.J. No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis. Mult Scler 13 (2007) 156-168
33. Tsantes A.E., Nikolopoulos G.K., Bagos P.G., Rapti E., Mantzios G., Kapsimali V., et al. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis. Thromb Haemost 97 (2007) 907-913
34. Nikolopoulos G.K., Tsantes A.E., Bagos P.G., Travlou A., and Vaiopoulos G. Integrin, alpha 2 gene C807T polymorphism and risk of ischemic stroke: a meta-analysis. Thromb Res 119 (2007) 501-510
35. Siffert W., Rosskopf D., Siffert G., Busch S., Moritz A., Erbel R., et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 18 (1998) 45-48
36. Harbo H.F., Celius E.G., Vartdal F., and Spurkland A. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens 53 (1999) 106-110
37. Barrowman N.J., Fang M., Sampson M., and Moher D. Identifying null meta-analyses that are ripe for updating. BMC Med Res Methodol 3 (2003) 13